Camp4 Therapeutics (CAMP)Director bought ~$10M

~$10M

Approx. value · 909K sh @ $11.00

2.63M

Holds after · shares reported

Traded

Oct 15, 2024

Filed

Oct 15, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 15, 2024 · this disclosureInsiderDirector purchased ~$10M of CAMP shares in the open market

What came next

1. Oct 15, 2024Insider · 6 peopleInsiders: 7 purchases (~$61.4M)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Camp4 Therapeutics

For Camp4 Therapeutics, OQRO holds 11 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CAMP page.

Other recent filings by Andrew J. Schwab, Director

• SEC Form 4 at Skye Bioscience (SKYE)Sep 24, 2026
• SEC Form 4 at Skye Bioscience (SKYE)Sep 24, 2026
• SEC Form 4 at Skye Bioscience (SKYE)Sep 24, 2026
• SEC Form 4 at Skye Bioscience (SKYE)Sep 24, 2026
• SEC Form 4 at Skye Bioscience (SKYE)Sep 18, 2026

The full history of Andrew J. Schwab, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Camp4 Therapeutics

• SEC Form 4Sep 2, 2026
• SEC Form 4Aug 31, 2026
• SEC Form 4Aug 26, 2026
• SEC Form 4Aug 21, 2026
• SEC Form 4Aug 21, 2026
• SEC Form 4Aug 21, 2026

Everything OQRO holds on this company is on its CAMP page.